Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Rainer Schwerdtfeger"'
Autor:
Eolia Brissot, Myriam Labopin, Matthias Stelljes, Gerhard Ehninger, Rainer Schwerdtfeger, Jürgen Finke, Hans-Jochem Kolb, Arnold Ganser, Kerstin Schäfer-Eckart, Axel R. Zander, Donald Bunjes, Stephan Mielke, Wolfgang A. Bethge, Noël Milpied, Peter Kalhs, Igor-Woflgang Blau, Nicolaus Kröger, Antonin Vitek, Martin Gramatzki, Ernst Holler, Christoph Schmid, Jordi Esteve, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-10 (2017)
Abstract Background Primary refractory acute myeloid leukemia (PRF-AML) is associated with a dismal prognosis. Allogeneic stem cell transplantation (HSCT) in active disease is an alternative therapeutic strategy. The increased availability of unrelat
Externí odkaz:
https://doaj.org/article/9d0a51f6b1c14c8989702f863a85f779
Autor:
Annalisa Ruggeri, Giorgia Battipaglia, Myriam Labopin, Gerhard Ehninger, Dietrich Beelen, Johanna Tischer, Arnold Ganser, Rainer Schwerdtfeger, Bertram Glass, Jurgen Finke, Mauricette Michallet, Matthias Stelljes, Pavel Jindra, Renate Arnold, Nicolaus Kröger, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-8 (2016)
Abstract Background Allogeneic stem cell transplantation is the only curative option for patients with acute myeloid leukemia (AML) experiencing relapse. Either matched sibling donor (MSD) or unrelated donor (UD) is indicated. Methods We analyzed 155
Externí odkaz:
https://doaj.org/article/e5135234ac2140389d8a22aad0b4fb06
Autor:
Marie T. Rubio, Bipin N. Savani, Myriam Labopin, Emmanuelle Polge, Dietger Niederwieser, Arnold Ganser, Rainer Schwerdtfeger, Gerhard Ehninger, Jürgen Finke, Arnold Renate, Charles Craddock, Nicolaus Kröger, Michael Hallek, Pavel Jindra, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-14 (2016)
Abstract Background Data comparing fully matched and mismatched-unrelated-donor (M- and mM-URD) allogeneic hematopoietic stem cell transplant (allo-SCT) following reduced intensity conditioning regimens for acute myeloid leukemia are limited. Methods
Externí odkaz:
https://doaj.org/article/96056c09c1a14aa1b47442a2f115d243
Autor:
Bipin N. Savani, Myriam Labopin, Nicolaus Kröger, Jürgen Finke, Gerhard Ehninger, Dietger Niederwieser, Rainer Schwerdtfeger, Donald Bunjes, Bertram Glass, Gerard Socié, Per Ljungman, Charles Craddock, Frédéric Baron, Fabio Ciceri, Norbert Claude Gorin, Jordi Esteve, Christoph Schmid, Sebastian Giebel, Mohamad Mohty, Arnon Nagler
Publikováno v:
Haematologica, Vol 101, Iss 6 (2016)
The outcome of patients undergoing HLA-matched unrelated donor allogeneic hematopoietic cell transplantation following reduced-intensity conditioning or myeloablative regimens is reported to be equivalent; however, it is not known if the intensity of
Externí odkaz:
https://doaj.org/article/da6c471795fa4b9c931b658e71e8ddf5
Autor:
Bipin N. Savani, Myriam Labopin, Didier Blaise, Dietger Niederwieser, Fabio Ciceri, Arnold Ganser, Renate Arnold, Boris Afanasyev, Stephane Vigouroux, Noel Milpied, Michael Hallek, Jan J. Cornelissen, Rainer Schwerdtfeger, Emmanuelle Polge, Frédéric Baron, Jordi Esteve, Norbert C. Gorin, Christoph Schmid, Sebastian Giebel, Mohamad Mohty, Arnon Nagler
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Increasing numbers of patients are receiving reduced intensity conditioning regimen allogeneic hematopoietic stem cell transplantation. We hypothesized that the use of bone marrow graft might decrease the risk of graft-versus-host disease compared to
Externí odkaz:
https://doaj.org/article/d9770cb9b1a14200a3cc7799007f239b
Autor:
Ali Bazarbachi, Myriam Labopin, Mohamed A. Kharfan-Dabaja, Rainer Schwerdtfeger, Liisa Volin, Jean Henri Bourhis, Gérard Socié, Etienne Daguindau, Tobias Gedde-Dahl, Alessandro Rambaldi, Michal Karas, Günter Schlimok, Didier Blaise, Patrice Chevallier, Florent Malard, Christoph Schmid, Jordi Esteve, Arnon Nagler, Mohamad Mohty
Publikováno v:
Haematologica, Vol 101, Iss 1 (2016)
Externí odkaz:
https://doaj.org/article/f187e4375232471593e845c69e192b28
Autor:
Mark Reinwald, Dieter Buchheidt, Margit Hummel, Matthias Duerken, Hartmut Bertz, Rainer Schwerdtfeger, Stefan Reuter, Michael G Kiehl, Manuel Barreto-Miranda, Wolf-Karsten Hofmann, Birgit Spiess
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56706 (2013)
Central nervous system (CNS) invasive aspergillosis (IA) is a fatal complication in immunocompromised patients. Confirming the diagnosis is rarely accomplished as invasive procedures are impaired by neutropenia and low platelet count. Cerebrospinal f
Externí odkaz:
https://doaj.org/article/bbf04703566144dbb4a06c15e8985f11
Autor:
Birgit Federmann, Martin Bornhauser, Christoph Meisner, Lambros Kordelas, Dietrich W. Beelen, Gernot Stuhler, Matthias Stelljes, Rainer Schwerdtfeger, Maximilian Christopeit, Gerhard Behre, Christoph Faul, Wichard Vogel, Michael Schumm, Rupert Handgretinger, Lothar Kanz, Wolfgang A. Bethge
Publikováno v:
Haematologica, Vol 97, Iss 10 (2012)
Background We report a prospective multicenter phase II study of haploidentical hematopoietic stem cell transplantation using CD3/CD19-depleted grafts after reduced intensity conditioning with fludarabine, thiotepa, melphalan and OKT-3.Design and Met
Externí odkaz:
https://doaj.org/article/2f84643d901a4eb59eebfe441c872aed
Autor:
Matthias Stelljes, Dietrich W. Beelen, Jan Braess, Maria C. Sauerland, Achim Heinecke, Björna Berning, Hans J. Kolb, Ernst Holler, Rainer Schwerdtfeger, Renate Arnold, Karsten Spiekermann, Carsten Müller-Tidow, Hubert L. Serve, Gerda Silling, Wolfgang Hiddemann, Wolfgang E. Berdel, Thomas Büchner, Joachim Kienast
Publikováno v:
Haematologica, Vol 96, Iss 7 (2011)
Background Allogeneic hematopoietic cell transplantation is considered the preferred post-remission therapy in patients with acute myeloid leukemia cytogenetically defined as being at high risk. To substantiate evidence for allogeneic hematopoietic c
Externí odkaz:
https://doaj.org/article/d52df787c6394936a3afffd6369f9fb7
Autor:
Francis Ayuk, José A. Perez-Simon, Avichai Shimoni, Anna Sureda, Tatjana Zabelina, Rainer Schwerdtfeger, Rodrigo Martino, Herbert Gottfried Sayer, Adrián Alegre, Juan-José Lahuerta, Djordje Atanackovic, Christine Wolschke, Arnon Nagler, Axel R. Zander, Jesús F. San Miguel, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 93, Iss 9 (2008)
Background Antithymocyte globulin or human Jurkat T-cell-line-derived antilymphocyte globulin is used in allogeneic stem cell transplantation to induce in vivo T-cell depletion to facilitate engraftment and lower graft-versus-host disease. In vitro s
Externí odkaz:
https://doaj.org/article/ea2d17720b504aaa9c1a66daef0b1c91